Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
drug
|
| gptkbp:approves |
gptkb:European_Union
|
| gptkbp:chemicalFormula |
C22H30N4O5S
|
| gptkbp:clinicalTrials |
Phase 2
|
| gptkbp:developedBy |
Oncopeptides AB
|
| https://www.w3.org/2000/01/rdf-schema#label |
Melflufen
|
| gptkbp:isATypeOf |
1234567-89-0
|
| gptkbp:issuedBy |
intravenous infusion
|
| gptkbp:targets |
hematological malignancies
|
| gptkbp:triggerType |
peptide-drug conjugate
|
| gptkbp:usedFor |
multiple myeloma
|